HOXB13 and breast cancer: The coordinated over-expression of HOXB13 and HBXIP induces TAM resistance in ERα BC cell models: HBXIP prevents chaperone-mediated-autophagy (CMA)-dependent degradation of HOXB13 through the acetylation of its K227 residue, causing HOXB13 accumulation.